Maxflex Named Key Supplier to Angelalign in Strategic Partnership

Shanghai, February 19, 2025 — Shanghai Maxflex Medical Technology Co., Ltd. ("Maxflex") announced a strategic partnership with Angelalign Technology Inc. ("Angelalign", Stock Code: 6699), a global leader in clear aligner solutions. The two parties have entered into a Product Purchase Cooperation Framework Agreement, designating Maxflex as a core raw material supplier for Angelalign’s clear aligner manufacturing.

Under the agreement effective until December 31, 2027, Angelalign’s wholly owned subsidiary Wuxi EA will procure specialized raw materials from Maxflex for clear aligner production. The contract sets annual procurement caps of RMB 30.0 million (2025), RMB 42.0 million (2026), and RMB 58.8 million (2027), totaling over RMB 126 million across three years. This commitment underscores Angelalign’s long-term confidence in Maxflex’s product quality and supply chain capabilities.

As a leading supplier in the clear aligner industry, Maxflex drives innovation in medical-grade materials and equipment. This partnership enhances industrial synergy and supports Angelalign’s global expansion—its business spans 50+ countries across EMEA, Asia-Pacific, and the Americas. Angelalign’s Board stated: "Collaborating with Maxflex on arm’s length commercial terms ensures competitive pricing and aligns with the interests of our shareholders.